InvestorsHub Logo
Followers 20
Posts 5392
Boards Moderated 0
Alias Born 01/04/2012

Re: justabroker_2000 post# 11632

Friday, 02/17/2012 4:43:44 PM

Friday, February 17, 2012 4:43:44 PM

Post# of 26138
According to the PR dated Jan 31 2012, It is BioSante's objective to meet with the FDA to determine the best path forward, and to make a decision whether to continue the LibiGel safety study within the next 90 days. Hopefully we will hear something before April 31st.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.